These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2822155)

  • 21. A comparison of adrenal cortical function in patients with depressive illness and Cushing's disease.
    Schlechte JA; Sherman B; Pfohl B
    Horm Res; 1986; 23(1):1-8. PubMed ID: 3940937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
    Watanobe H; Tamura T
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ACTH stimulation test before and after clinical recovery from depression.
    Amsterdam JD; Maislin G; Droba M; Winokur A
    Psychiatry Res; 1987 Apr; 20(4):325-36. PubMed ID: 3037578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cortisol, ACTH, and beta-endorphin after dexamethasone administration in Parkinson's dementia.
    Rabey JM; Scharf M; Oberman Z; Zohar M; Graff E
    Biol Psychiatry; 1990 Mar; 27(6):581-91. PubMed ID: 2157505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New diagnostic criteria of adrenal subclinical Cushing's syndrome: opinion from the Japan Endocrine Society.
    Yanase T; Oki Y; Katabami T; Otsuki M; Kageyama K; Tanaka T; Kawate H; Tanabe M; Doi M; Akehi Y; Ichijo T
    Endocr J; 2018 Apr; 65(4):383-393. PubMed ID: 29576599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
    al-Saadi N; Diederich S; Oelkers W
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):45-51. PubMed ID: 9509067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of atrial natriuretic factor infusion on basal and CRH-stimulated ACTH, cortisol and aldosterone levels in patients with Cushing's or Addison's disease.
    Ambrosi B; Sala C; Bochicchio D; Colombo P; Gazzano G; Fadin C; Morganti A; Faglia G
    Clin Endocrinol (Oxf); 1994 May; 40(5):589-94. PubMed ID: 8013139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cortisol, ACTH, and dexamethasone concentrations in a psychogeriatric population.
    Ferrier IN; Pascual J; Charlton BG; Wright C; Leake A; Griffiths HW; Fairbairn AF; Edwardson JA
    Biol Psychiatry; 1988 Feb; 23(3):252-60. PubMed ID: 2892542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship of bioassayable and immunoassayable plasma ACTH and cortisol concentrations in normal subjects and in patients with Cushing's disease.
    Krieger DT; Allen W
    J Clin Endocrinol Metab; 1975 Apr; 40(4):675-87. PubMed ID: 165214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Release of corticotropin after administration of corticotropin-releasing hormone in depressed patients in relation to the dexamethasone suppression test.
    Thalén BE; Kjellman BF; Ljunggren JG; Akner G; Kågedal B; Wahlund B; Wetterberg L
    Acta Psychiatr Scand; 1993 Feb; 87(2):133-40. PubMed ID: 8383420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple steroid hormone levels in depressed patients and normal controls before and after exogenous ACTH.
    Gehris TL; Kathol R; Meller WH; Lopez JF; Jaeckle RS
    Psychoneuroendocrinology; 1991; 16(6):481-97. PubMed ID: 1667335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC; Raff H; Findling JW
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FK 33-824, a met-enkephalin analog, blocks corticotropin-releasing hormone-induced adrenocorticotropin secretion in normal subjects but not in patients with Cushing's disease.
    Allolio B; Deuss U; Kaulen D; Leonhardt U; Kallabis D; Hamel E; Winkelmann W
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1427-31. PubMed ID: 3023423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twelve-hour cycles of adrenocorticotropin and cortisol secretion in Cushing's disease.
    Schteingart DE; McKenzie AK
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1195-8. PubMed ID: 6252234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of low dose (1 microg) ACTH stimulation test in the investigation of non-classic adrenal hyperplasia due to 11beta-hydroxylase deficiency.
    Unlühizarci K; Keleştimur F; Güven M; Bayram F; Colak R
    Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):381-5. PubMed ID: 12518247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationships of historically defined subtypes of depression to ACTH and cortisol levels in depression: preliminary study.
    Winokur G; Pfohl B; Sherman B
    Biol Psychiatry; 1985 Jul; 20(7):751-7. PubMed ID: 2988656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of ketoconazole in the treatment of Cushing's syndrome.
    Loli P; Berselli ME; Tagliaferri M
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1365-71. PubMed ID: 3023421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Etomidate: a selective adrenocortical 11 beta-hydroxylase inhibitor.
    Dörr HG; Kuhnle U; Holthausen H; Bidlingmaier F; Knorr D
    Klin Wochenschr; 1984 Nov; 62(21):1011-3. PubMed ID: 6096625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasopressin responsiveness of subclinical Cushing's syndrome due to ACTH-independent macronodular adrenocortical hyperplasia.
    Tatsuno I; Uchida D; Tanaka T; Koide H; Shigeta A; Ichikawa T; Sasano H; Saito Y
    Clin Endocrinol (Oxf); 2004 Feb; 60(2):192-200. PubMed ID: 14725680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.